The DOI matches its Crossref record; 473 of the 473 references it cites were found in a registry or an index.
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Abstract
WHAT’S NEW SINCE THE 2010 GUIDELINES? Inclusion of guidance for the diagnosis and management of cholangiocarcinoma (CCA) in patients with and without primary sclerosing cholangitis (PSC) (Figures 5, 8, and 9). Introduction of the term relevant stricture, defined as any biliary stricture of the common hepatic duct or hepatic ducts associated with signs or symptoms of obstructive cholestasis and/or bacterial cholangitis (Table 1). In patients with equivocal MRI with cholangiopancreatography (MRI/MRCP) findings, a repeated high‐quality MRI/MRCP should be performed for diagnostic purposes. Endoscopic retrograde cholangiopancreatography (ERCP) should be avoided for the diagnosis of PSC (Figure 2). In patients with PSC without known inflammatory bowel disease (IBD), diagnostic colonoscopy with histological sampling should be performed and may be repeated every 5 years if IBD is not initially detected. Colon cancer surveillance should begin at age 15 years in patients with PSC and IBD. New clinical risk tools for PSC are available for risk stratification, but probabilities of events in individual patients should be interpreted with caution (Figure 4 and Table 3). All patients with PSC should be considered for participation in clinical trials; however, ursodeoxycholic acid (13–23 mg/kg/day) can be considered and continued if well tolerated with a meaningful improvement in alkaline phosphatase (γ‐glutamyl transferase in children) and/or symptoms with 12 months of treatment. ERCP with biliary brushings for cytology and fluorescent in situ hybridization analysis should be obtained in all patients with suspected perihilar or distal CCA. There is a new United Network for Organ Sharing policy regarding standardization of Model for End‐Stage Liver Disease exceptions for patients with PSC and recurrent cholangitis. Liver transplantation following neoadjuvant therapy is recommended for patients with perihilar CCA < 3 cm in radial diameter that is unresectable or arising in the setting of PSC and in the absence of intrahepatic or extrahepatic metastasis (Figure 9). TABLE 1 - Definitions in PSC PSC Chronic, cholestatic liver disease likely of autoimmune origin characterized by inflammation and fibrosis of intrahepatic and/or extrahepatic bile ducts, leading to the formation of bile duct strictures, and frequently associated with IBD Small‐duct PSC Less common variant of PSC that is characterized by typical cholestatic and histological features of PSC but with normal bile ducts on cholangiography PSC–AIH overlap Concurrent diagnostic features of PSC and clinical, biochemical, and histological features of AIH Secondary sclerosing cholangitis Biliary strictures due to identifiable causes that can result in secondary biliary cirrhosis IgG4 sclerosing cholangitis Biliary strictures due to elevated IgG4‐positive plasma cells in tissue and serum IgG4 elevation frequently associated with pancreatic involvement Dominant stricture A biliary stricture on ERCP with a diameter of ≤1.5 mm in the common bile duct or of ≤1 mm in the hepatic duct High‐grade stricture A biliary stricture on MRI with cholangiopancreatography with >75% reduction in the common bile duct or hepatic ducts Relevant stricture Any biliary stricture of the common bile duct or hepatic ducts associated with signs or symptoms of obstructive cholestasis and/or bacterial cholangitis INTRODUCTION AND SCOPE OF GUIDANCE Primary sclerosing cholangitis (PSC) is a cholangiopathy characterized by chronic fibroinflammatory damage of the biliary tree and is frequently associated with inflammatory bowel disease (IBD). The majority of patients with PSC have fibrotic biliary strictures on cholangiogram, whereas a minority have small‐duct PSC, characterized by a normal cholangiogram but with histological features of PSC on liver biopsy. A small percentage have overlapping features of autoimmune hepatitis (PSC‐AIH). PSC affects both male and female individuals and can occur at any age. PSC is considered an autoimmune disease, though the pathophysiology remains poorly understood. PSC frequently results in cholestatic liver damage, cirrhosis, and liver failure and can recur in 20%–30% of patients PSC the risk of cholangiocarcinoma (CCA) and cancer is therapy for PSC, and clinical with a of diagnostic for A of new biliary strictures, is in Table for the of Liver guidance a to the diagnosis and management of PSC and CCA. are by of the of the of the and of the if of results the of and In guidance by of an and guidance on and analysis of the on the with by the at all of guidance The to a guidance on a of not available to the of a meaningful In to the of to the 2010 new for the of biliary strictures, an on for diagnosis retrograde cholangiopancreatography (ERCP) and liver of and for clinical and management of OF PSC of PSC have The majority of to have in and of and are and have that the and of PSC may be of the a PSC to the United and the United to be by PSC at to of PSC is the of and with a ag
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–473 of 473
Edmunds, C., & Ekong, U. D. (2015) · Transplantation · doi:10.1097/tp.0000000000000922 · Cited by 44
Bile duct calculi in patients with primary sclerosing cholangitis.
Dodd, G. D., Niedzwiecki, G. A., Campbell, W. L., & BARON, R. L. (1997) · Radiology · doi:10.1148/radiology.203.2.9114102 · Cited by 43
Hilscher, M. B., Tabibian, J. H., Carey, E. J., Gostout, C. J., & Lindor, K. D. (2018) · Hepatology Communications · doi:10.1002/hep4.1194 · Cited by 43
Self-citationTh17 cell frequency is associated with low bone mass in primary sclerosing cholangitis
Schmidt, T., Schwinge, D., Rolvien, T., Jeschke, A., Schmidt, C., Neven, M., Butscheidt, S., Kriz, M., Kunzmann, L., Mussawy, H., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.12.035 · Cited by 42
High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis
Harnois, D. M., Angulo, P., Jorgensen, R. A., Keach, J. C., LaRusso, N. F., & Lindor, K. D. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)85744-3 · Cited by 41
Gotthardt, D. N., Rupp, C., Bruhin, M., Schellberg, D., Weiss, K. H., Stefan, R., Donnerstag, N., Stremmel, W., Löwe, B., Juenger, J., et al. (2014) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000223 · Cited by 41
Nielsen, M. J., Thorburn, D., Leeming, D. J., Hov, J. R., Nygård, S., Moum, B. A., Saffioti, F., Gilja, O. H., Boberg, K. M., Mazza, G., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14806 · Cited by 40
Tenca, A., Mustonen, H. K., Lind, K., Lantto, E., Kolho, K., Boyd, S., Arola, J., Jokelainen, K., & Färkkilä, M. A. (2018) · Liver International · doi:10.1111/liv.13899 · Cited by 39
Probert, C. S., Christ, A. D., Saubermann, L. J., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.4.1941 · Cited by 38
Terg, R., Sambuelli, A. M., Coronel, E., Mazzuco, J., Cartier, M., Negreira, S., Muñoz, A., Gil, A. H., Míguez, C., Huernos, S. P., et al. (2008) · PubMed · Cited by 38
Tietz-Bogert, P. S., Kim, M., Cheung, A., Tabibian, J. H., Heimbach, J. K., Rosen, C. B. B., Nandakumar, M., Lazaridis, K. N., LaRusso, N. F., Sung, J., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103188 · Cited by 38
Self-citationTafur, M., Cheung, A., Menezes, R. J., Feld, J. J., Janssen, H. L. A., Hirschfield, G. M., & Jhaveri, K. S. (2020) · European Radiology · doi:10.1007/s00330-020-06728-6 · Cited by 37
Risk factors for primary sclerosing cholangitis
Boonstra, K., de Vries, E. M. G., van Geloven, N., van Erpecum, K. J., Spanier, M., Poen, A. C., van Nieuwkerk, C. M., Witteman, B. J. M., Tuynman, H. A. R. E., Naber, A. H. J., et al. (2015) · Liver International · doi:10.1111/liv.12894 · Cited by 36
Impact of experimental colitis on hepatobiliary transporter expression and bile duct injury in mice
Jahnel, J., Fickert, P., Langner, C., Högenauer, C., Silbert, D., Gumhold, J., Fuchsbichler, A., & Trauner, M. A. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02044.x · Cited by 36
Are Dominant Strictures in Primary Sclerosing Cholangitis a Risk Factor for Cholangiocarcinoma?
Chapman, R. W., & Williamson, K. D. (2017) · Current Hepatology Reports · doi:10.1007/s11901-017-0341-2 · Cited by 36
Fischer, S. E., Trivedi, P. J., Ward, S., Greig, P. D., Therapondos, G., & Hirschfield, G. M. (2014) · International Journal of Experimental Pathology · doi:10.1111/iep.12076 · Cited by 35
Culver, E. L., Bungay, H. K., Betts, M., Forde, C., Buchel, O. C., Manganis, C., Warren, B. F., Cummings, F. J. R., Keshav, S., Travis, S. P. L., et al. (2020) · Liver International · doi:10.1111/liv.14645 · Cited by 35
Cholangiocarcinoma miscoding in hepatobiliary centres
Selvadurai, S., Mann, K., Mithra, S., Bridgewater, J. A., Malik, H., & Khan, S. A. (2020) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2020.09.039 · Cited by 35
Smets, L., Verbeek, J., Korf, H., van der Merwe, S., Nevens, F., et al. (2021) · Hepatology · doi:10.1002/hep.31613 · Cited by 34
Gilligan, L. A., Trout, A. T., Lam, S., Singh, R., Tkach, J. A., Serai, S. D., Miethke, A. G., & Dillman, J. R. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-02184-z · Cited by 34
An Imaging Biomarker for Assessing Hepatic Function in Patients With Primary Sclerosing Cholangitis
Schulze, J., Lenzen, H., Hinrichs, J. B., Ringe, B., Manns, M. P., Wacker, F. K., & Ringe, K. I. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.05.011 · Cited by 33
Recurrence of primary sclerosing cholangitis in pediatric liver transplant recipients
Venkat, V. L., Ranganathan, S., Mazariegos, G. V., Sun, Q., & Sindhi, R. K. (2014) · Liver Transplantation · doi:10.1002/lt.23868 · Cited by 32
Kerr, S. E., Fritcher, E. G. B., Campion, M. B., Voss, J. S., Kipp, B. R., Halling, K. C., & Lewis, J. T. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.05.008 · Cited by 32
Autoimmune Hepatitis Overlap Syndromes and Liver Pathology
Czaja, A. J., & Carpenter, H. A. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2017.01.008 · Cited by 32
Primary Sclerosing Cholangitis Is Not Rare Among Blacks in a Multicenter North American Consortium
Goldberg, D. S., Levy, C., Yimam, K. K., Gordon, S. C., Forman, L., Verna, E. C., Yu, L., Rahimi, R. S., Schwarz, K. B., Eksteen, B., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.10.028 · Cited by 31
Self-citationSagvand, B. T., Edwards, K., & Shen, B. (2018) · Hepatology Communications · doi:10.1002/hep4.1276 · Cited by 31
Abnormal Liver Biochemistry Is Common in Pediatric Inflammatory Bowel Disease
Valentino, P. L., Feldman, B. M., Walters, T. D., Griffiths, A. M., Ling, S. C., Pullenayegum, E., & Kamath, B. M. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000558 · Cited by 30
Alexopoulou, E., Xenophontos, P. E., Economopoulos, N., Spyridopoulos, T. N., Papakonstantinou, O., Panayotou, I., Dimakou, K., Roma, E. S., & Kelekis, N. (2012) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31825bb3dc · Cited by 30
Peng, X., Luo, X., Hou, J.-Y., Wu, S., Li, L.-Z., Zheng, M., & Wang, L. (2017) · Digestive Diseases · doi:10.1159/000471874 · Cited by 30
Lian, M., Li, B., Xiao, X., Yang, Y., Jiang, P., Li, Y., Sun, C., Zhang, J., Wei, Y., Li, Y., et al. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.05.018 · Cited by 30
El‐Matary, W., Guthery, S. L., Amir, A. Z., DiGuglielmo, M., Draijer, L. G., Furuya, K. N., Gupta, N. A., Hochberg, J. T., Horslen, S. P., Kerkar, N. N., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.04.055 · Cited by 29
Self-citationBerglin, L., Bergquist, A. M., Johansson, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105375 · Cited by 28
Self-citationPrimary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease in Turkey
Parlak, E., Koşar, Y., Ülker, A., Dağlı, Ü., Alkım, C., & Şahın, B. (2001) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200110000-00008 · Cited by 28
Evolving role of magnetic resonance techniques in primary sclerosing cholangitis
Selvaraj, E. A., Culver, E. L., Bungay, H. K., Bailey, A. A., Chapman, R. W., & Pavlides, M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i6.644 · Cited by 28
Swensson, J., Tirkes, T., Tann, M. A., Cui, E., & Sandrasegaran, K. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-01944-1 · Cited by 28
Lam, S., Singh, R., Dillman, J. R., Trout, A. T., Serai, S. D., Sharma, D., Sheridan, R. M., Su, W., Fei, L., Karns, R. A., et al. (2020) · Hepatology Communications · doi:10.1002/hep4.1589 · Cited by 28
Ranieri, V., Kennedy, E., Walmsley, M., Thorburn, D., & McKay, K. (2020) · PLOS ONE · doi:10.1371/journal.pone.0234624 · Cited by 27
Isa, F., Turner, G., Kaur, G., Kyte, D. G., Slade, A. L., Pankhurst, T., Kerecuk, L., Keeley, T., Ferguson, J., & Calvert, M. (2018) · Health and Quality of Life Outcomes · doi:10.1186/s12955-018-0951-6 · Cited by 27
Liver transplantation for hilar cholangiocarcinoma—a single-centre experience
Schüle, S., Altendorf-Hofmann, A., Uteß, F., Rauchfuß, F., Freesmeyer, M. G., Knösel, T., Dittmar, Y., & Settmacher, U. (2012) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-012-1007-8 · Cited by 26
Belle, A., Laurent, V., Pouillon, L., Baumann, C., Orry, X., Lopez, A., Rousseau, H., Bronowicki, J., & Peyrin‐Biroulet, L. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.06.024 · Cited by 26
Colitis Promotes a Pathological Condition of the Liver in the Absence of Foxp3+ Regulatory T Cells
Mathies, F. L., Steffens, N., Kleinschmidt, D., Stuhlmann, F., Huber, F. J., Roy, U., Meyer, T., Luetgehetmann, M., von Petersdorff, M., Seiz, O., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800711 · Cited by 26
Satapathy, S. K., Jones, O. D., Vanatta, J. M., Kamal, F., Kedia, S., Jiang, Y., Nair, S. P., & Eason, J. D. (2017) · Transplantation Direct · doi:10.1097/txd.0000000000000693 · Cited by 25
Biliary endoscopy in the management of primary sclerosing cholangitis and its complications
Fung, B. M., & Tabibian, J. H. (2019) · Liver Research · doi:10.1016/j.livres.2019.03.004 · Cited by 25
Self-citationMartínez, M., Perito, E. R., Valentino, P. L., Mack, C. L., Aumar, M., Broderick, A., Draijer, L. G., Fagundes, E. D. T., Furuya, K. N., Gupta, N. A., et al. (2021) · Hepatology · doi:10.1002/hep.31911 · Cited by 25
Self-citationBlack, D. D., Mack, C. L., Kerkar, N. N., Miloh, T., Sundaram, S. S., Anand, R., Gupta, A., Alonso, E. M., Arnon, R., Bulut, P., et al. (2019) · Hepatology Communications · doi:10.1002/hep4.1421 · Cited by 24
Draiweesh, S. A., Ma, C., Alkhattabi, M. S., McDonald, C. L., Nguyen, T. M., Beaton, M. D., Chande, N., Colquhoun, P. H. D., Feagan, B. G., Gregor, J. C., et al. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz244 · Cited by 24
Krawczyk, M. J., Ligocka, J., Ligocki, M., Raszeja‐Wyszomirska, J., Milkiewicz, M., Szparecki, G., Ilczuk, T., Górnicka, B., Zieniewicz, K., Krawczyk, M., et al. (2017) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2017.1370009 · Cited by 23
Rönnblom, A., Holmström, T., Tanghöj, H., Rorsman, F., & Sjöberg, D. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12947 · Cited by 21
Marchan, E. M., & Landry, J. C. (2016) · PubMed · doi:10.3978/j.issn.2078-6891.2015.117 · Cited by 21
Grigoriadis, A., Morsbach, F., Voulgarakis, N., Said, K., Bergquist, A. M., & Kartalis, N. (2020) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2020.1720281 · Cited by 21
Self-citationSingh, K. S., Khoury, A. A., Kürti, Z., Gönczi, L., Reinglas, J., Verdon, C., Kohen, R., Bessissow, T., Afif, W., Wild, G., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz066 · Cited by 20
Chapman, M. H., Webster, G., Bannoo, S., Johnson, G., Wittmann, J., & Pereira, S. P. (2012) · UCL Discovery (University College London) · Cited by 20
van Munster, K. N., Dijkgraaf, M. G. W., van Gennep, S., Beuers, U. H., & Ponsioen, C. Y. (2020) · Liver International · doi:10.1111/liv.14644 · Cited by 19
Primary Sclerosing Cholangitis and Primary Biliary Cirrhosis Overlap Syndrome: A Review
Mago, S., & Wu, G. Y. (2020) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00036 · Cited by 19
Liu, X., Wang, H., Liu, X., Bridle, K. R., Crawford, D. H., & Liang, X. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108163 · Cited by 19
Patil, K., Ricciuto, A., Alsharief, A., Al‐Rayahi, J., Amirabadi, A., Church, P. C., Kamath, B. M., & Greer, M. C. (2020) · Hepatology Communications · doi:10.1002/hep4.1454 · Cited by 18
Raszeja‐Wyszomirska, J., Kucharski, R., Zygmunt, M., Safranow, K., & Miazgowski, T. (2015) · Hepatitis Monthly · doi:10.5812/hepatmon.25539 · Cited by 15
Prevalence of inflammatory bowel disease among patients with primary sclerosing cholangitis in Iran
Hadizadeh, M. R., Abedi, S. H., Malekpour, H., Radinnia, E., Jabbehdari, S., Padashi, M., Zali, M. R., & Alizadeh, A. H. M. (2016) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2015.09.004 · Cited by 15
Ong, J., Bath, M., Swift, C., & Al‐Naeeb, Y. (2018) · Gastroenterology and hepatology from bed to bench. · doi:10.17863/cam.52127 · Cited by 15
Khorashad, A. K., Khajedaluee, M., Amirmajdi, E. M., Bahari, A., Farzanehfar, M., Ahadi, M., Abedini, S., Abdollahi, M. R., Vakili, R., & Nia, H. V. (2015) · Gastroenterology and hepatology from bed to bench. · Cited by 14
Lampinen, M., Fredricsson, A., Vessby, J., Martinez, J. F., Wanders, A., Rorsman, F., & Carlson, M. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ma0517-175r · Cited by 14
Nutritional Management of Cholestasis
Send, S. (2020) · Clinical Liver Disease · doi:10.1002/cld.865 · Cited by 14
Efficacy of bezafibrate in a patient with primary sclerosing cholangitis
Kurihara, T., Maeda, A., Shigemoto, M., Yamashita, K., & Kamatani, N. (2003) · Journal of Gastroenterology · doi:10.1007/s005350300053 · Cited by 13
Efficacy and safety of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy.
Pařı́zek, A., Šimják, P., Černý, A., Sestinová, A., Zdeňková, A., Hill, M., Dušková, M., Vlk, R., Kokrdová, Z., Koucký, M., et al. (2016) · PubMed · doi:10.5604/16652681.1212562 · Cited by 12
Keller, S., Aigner, A., Zenouzi, R., Kim, A. C., Meijer, A. C., Weidemann, S. A., Krech, T., Lohse, A. W., Adam, G., Schramm, C., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193929 · Cited by 12
Wunsch, E., Stadnik, A., Kruk, B., Szczepankiewicz, B., Kotarska, K., Krawczyk, M. J., Górnicka, B., Wójcicki, M., & Milkiewicz, P. (2021) · Liver Transplantation · doi:10.1002/lt.26033 · Cited by 12
A novel, minimally invasive technique for management of peristomal varices
Tabibian, J. H., Dayyeh, B. K. A., Gores, G. J., & Levy, M. J. (2015) · Hepatology · doi:10.1002/hep.27925 · Cited by 11
Self-citationAnthropometric Measurements and Frailty in Patients with Liver Diseases
Nishikawa, H., Yoh, K., Enomoto, H., Ikeda, N., Aizawa, N., Koriyama, T., Nishimura, T., Nishiguchi, S., & Iijima, H. (2020) · Diagnostics · doi:10.3390/diagnostics10060433 · Cited by 11
Oral nicotine in the treatment of primary sclerosing cholangitis: A pilot study
Angulo, P. G., Bharucha, A. E., Jorgensen, R. A., et al. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)84884-1 · Cited by 10
Song, C., Lewis, S. C., Kamath, A., Hectors, S. J. C. G., Putra, J., Kihira, S., Bane, O., Ahmad, J., Babb, J. S., Thung, S. N., et al. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-02366-9 · Cited by 10
Potential Association of Doxycycline With the Onset of Primary Sclerosing Cholangitis: A Case Series
Buness, J. G., Ali, A. H., Tabibian, J. H., Buness, C. W., Cox, K. L., & Lindor, K. D. (2019) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001065 · Cited by 7
Self-citationTherapeutic plasma exchange for intractable pruritus secondary to primary sclerosing cholangitis
Gibson, B., Williams, L. A., Marques, M. B., & Pham, H. P. (2015) · Journal of Clinical Apheresis · doi:10.1002/jca.21436 · Cited by 5
Koczka, C. P., Geraldino-Pardilla, L. B., & Lawlor, G. O. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31829455b5 · Cited by 4
Cited by
Sex differences in chronic liver disease and benign liver lesions
Cooper, K. M., Delk, M., Devuni, D., & Sarkar, M. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100870 · Cited by 38
Immunobiology of primary sclerosing cholangitis
Cornillet, M., Geanon, D., Bergquist, A., & Björkström, N. K. (2025) · Hepatology · doi:10.1097/hep.0000000000001080 · Cited by 20
Self-citation
Metadata
- Authors
- Bowlus, C. L., Arrivé, L., Bergquist, A., Deneau, M., Forman, L., Ilyas, S. I., Lunsford, K. E., Martinez, M., Sapisochin, G., Shroff, R., Tabibian, J. H., & Assis, D. N.
- Venue
- Hepatology
- Published
- 2022-10-20
- Volume
- 77
- Issue
- 2
- Pages
- 659-702
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W4295048810
- Cited by
- 428
- References
- 473
- FWCI
- 33.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.